BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2020 9:16:00 AM | Browse: 703 | Download: 1124
 |
Received |
|
2020-04-13 17:54 |
|
Peer-Review Started |
|
2020-04-13 17:54 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-04-22 15:48 |
|
Revised |
|
2020-07-05 17:45 |
|
Second Decision |
|
2020-07-16 12:07 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-07-19 20:49 |
|
Articles in Press |
|
2020-07-19 20:49 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-08-10 02:32 |
|
Publish the Manuscript Online |
|
2020-08-25 09:16 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
“Six-and-twelve” score for outcome prediction of hepatocellular carcinoma following transarterial chemoembolization. In-depth analysis from a multicenter French cohort
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Xavier Adhoute, Guillaume Pénaranda, Jean-Luc Raoul, Jean-Pierre Bronowicki, Rodolphe Anty and Marc Bourlière |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Xavier Adhoute, MD, Doctor, Department of Gastroenterology and Hepatology, Hôpital Saint-Joseph, 26 Bd de Louvain, Marseille 13008, France. adhoute.xavier@neuf.fr |
| Key Words |
Hepatocellular carcinoma; Transarterial chemoembolization; “Six-and-twelve” score; Prognosis; Albumin-Bilirubin grade; Tumor nodularity, infiltrative nature of the tumor, alpha-fetoprotein, Child-Pugh class, and performance status score |
| Core Tip |
Not all-intermediate stage hepatocellular carcinoma (HCC) benefit from transarterial chemoembolization (TACE). The recent “six-and-twelve” (6&12) score is an easy to use prognostic model that ensure a quick and appropriate patient’ selection before the first TACE in Chinese cohorts. In this multicenter French cohort of HCC, the “6&12” score can also classify survival among recommended TACE candidates with a good prognostic performance. It may help clinicians in routine clinical practice. |
| Publish Date |
2020-08-25 09:16 |
| Citation |
Adhoute X, Pénaranda G, Raoul JL, Bronowicki JP, Anty R, Bourlière M. “Six-and-twelve” score for outcome prediction of hepatocellular carcinoma following transarterial chemoembolization. In-depth analysis from a multicenter French cohort. World J Hepatol 2020; 12(8): 525-532 |
| URL |
https://www.wjgnet.com/1948-5182/full/v12/i8/525.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v12.i8.525 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
